PRRT2 and acute myeloid leukemia: In this context, it is noteworthy that both PKC [49] and CK2 [50] inhibitors have proved effective in AML, although it remains to be determined whether AML cells are expressing a HOX-containing chimeric protein and relatively more sensitive to these inhibitors.